| Larry Dean Jensen, DPM | |
|
11815 Sw King James Place, Suite 60, Tigard, OR 97224 | |
| (503) 639-8107 | |
| (503) 639-8108 |
| Full Name | Larry Dean Jensen |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Foot Surgery |
| Location | 11815 Sw King James Place, Tigard, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851383269 | NPI | - | NPPES |
| 000265 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | DP00199 (Oregon) | Primary |
| Provider Name | Fanno Creek Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609876705 PECOS PAC ID: 0042100521 Enrollment ID: O20040318000244 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
Significant quality challenges persist in antipsychotic medication use for children in foster care and other Medicaid-insured children, according to a new Rutgers University-New Brunswick study published in Health Affairs.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Larry Dean Jensen, DPM 11815 Sw King James Place, Suite 60, Tigard, OR 97224 Ph: (503) 639-8107 | Larry Dean Jensen, DPM 11815 Sw King James Place, Suite 60, Tigard, OR 97224 Ph: (503) 639-8107 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
Significant quality challenges persist in antipsychotic medication use for children in foster care and other Medicaid-insured children, according to a new Rutgers University-New Brunswick study published in Health Affairs.
The Hill's Healthwatch Blog: "The House passed six health-related bills Wednesday evening, including efforts to combat Medicare fraud and dispose of unused prescription drugs." The measures were approved under suspension of the rules, "an expedited procedure that only allows for 40 minutes of debate followed by a voice vote."
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
› Verified 8 days ago
Mr. Stephen M Schroeder, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7300 Sw Childs Rd, #b, Tigard, OR 97224 Phone: 503-692-8700 Fax: 503-692-8710 | |
Larry D Jensen Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 11815 Sw King James Pl, Suite 60, Tigard, OR 97224 Phone: 503-639-8107 Fax: 503-639-8108 | |
Yama Ahmad Dehqanzada, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9900 Sw Hall Blvd, Suite 100, Tigard, OR 97223 Phone: 503-245-2420 Fax: 503-245-2445 | |
Ejiro C Isiorho, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 11515 Sw Durham Road, E1, Tigard, OR 97224 Phone: 503-624-0364 Fax: 503-684-3306 | |
Westside Podiatry Clinic Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9900 Sw Hall Blvd, Suit 100, Tigard, OR 97223 Phone: 503-245-2420 Fax: 503-245-2445 | |
Paul Logan Williams, Podiatrist Medicare: Medicare Enrolled Practice Location: 11815 Sw King James Pl Ste 60, Tigard, OR 97224 Phone: 503-639-8107 | |
Todd Galle, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9900 Sw Hall Bvld, Suite 100, Tigard, OR 97223 Phone: 503-245-2420 Fax: 503-245-2445 |